EDITAS MEDICINE, INC. Class of Warrant or Right, Number of Securities Called by Warrants or Rights
EDITAS MEDICINE, INC. (EDIT) had Class of Warrant or Right, Number of Securities Called by Warrants or Rights of 23.08 thousand shares as of 2016-02-29, per its 10-K filed 2017-03-03.
Discontinued › Notes
us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights · last filed 2017-03-03
- 2016-02-29: Class of Warrant or Right, Number of Securities Called by Warrants or Rights 23.08K shares.
| Period end | Class of Warrant or Right, Number of Securities Called by Warrants or Rights |
|---|---|
| 2016-02-29 | 23.08K shares 10-K · filed 2017-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |